1. Home
  2. ROAD vs SYRE Comparison

ROAD vs SYRE Comparison

Compare ROAD & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Construction Partners Inc.

ROAD

Construction Partners Inc.

HOLD

Current Price

$102.85

Market Cap

6.4B

Sector

Industrials

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$88.72

Market Cap

6.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROAD
SYRE
Founded
2001
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
6.5B
IPO Year
2018
2015

Fundamental Metrics

Financial Performance
Metric
ROAD
SYRE
Price
$102.85
$88.72
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
12
Target Price
$127.80
$85.08
AVG Volume (30 Days)
658.2K
1.7M
Earning Date
05-08-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
40.46
N/A
EPS
0.47
N/A
Revenue
$785,679,000.00
N/A
Revenue This Year
$27.79
N/A
Revenue Next Year
$10.29
N/A
P/E Ratio
$229.77
N/A
Revenue Growth
0.31
N/A
52 Week Low
$93.22
$14.51
52 Week High
$151.00
$102.06

Technical Indicators

Market Signals
Indicator
ROAD
SYRE
Relative Strength Index (RSI) 34.22 57.28
Support Level $95.01 $66.78
Resistance Level $117.31 $102.06
Average True Range (ATR) 6.00 4.86
MACD -1.87 -0.58
Stochastic Oscillator 1.25 36.87

Price Performance

Historical Comparison
ROAD
SYRE

About ROAD Construction Partners Inc.

Construction Partners Inc operates as a civil infrastructure company. It specializes in the construction and maintenance of roadways. The company through its subsidiaries, provides various products and services to both public and private infrastructure projects, with an emphasis on highways, roads, bridges, airports, and commercial and residential developments. Its operations consist of manufacturing and distributing hot mix asphalt, paving activities, including the construction of roadway base layers and application of asphalt pavement, site development, including the installation of utility and drainage systems, and others. The company has a single segment which predominantly consists of infrastructure and road construction, and operates across various states in the United States.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel disease (IBD) and rheumatic diseases. Spyre's pipeline includes extended half-life antibodies targeting α4β7, TL1A, and IL-23 in development as monotherapies and pair-wise combinations. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: